By rray, 31 October, 2023 Don t give palivizumab later in the same RSV season However nbsp If an infant has already received
By rray, 31 October, 2023 Pregnant pts Encourage them to receive Abrysvo respiratory syncytial virus vaccine RSVpreF at 32 36 wk gestation during RSV season Sept Jan in most of the U S Don t use Arexvy RSVPreF3 in pregnant pts Administration of both Abrysvo to pregnant pts and nir
By rray, 31 October, 2023 American Indian and Alaska Native children 8 19 mo Continue offering nirsevimab to those not eligible for palivizumab who live in remote regions or in communities w high rates of severe RSV among older infants and toddlers 1
By rray, 31 October, 2023 Palivizumab eligible children 8 19 mo Suspend use of nirsevimab for the 2023 2024 RSV season and give palivizumab Synagis 1 2 nbsp Palivizumab ppx is recommended for infants in the 1st year of life born before 29 wk gestation preterm infants in the 1st ye
By rray, 31 October, 2023 Infants weighing 5 kg 11 lb Avoid using two 50 mg nirsevimab doses Prioritize using 100 mg doses in those at highest risk of severe RSV dz 1 nbsp Infants